Herpes zoster in frail elderly patients: prevalence, impact, management, and preventive strategies
- 2 May 2018
- journal article
- review article
- Published by Springer Nature in Aging Clinical and Experimental Research
- Vol. 30 (7) , 693-702
Abstract
Population aging is a worldwide phenomenon with significant and manifold impacts on society. Advanced age correlates with the onset of frailty. In this vulnerable state, the immune response is weakened and a higher susceptibility to infectious diseases is observed. The present narrative review aims to cover the topic of herpes zoster (HZ) and its complications in frail populations. The lifetime risk of developing HZ is estimated at about 20–30%, and the risk increases with age. In older people, HZ can lead to the inability to recover the lifestyle, the interests, and the level of activity that existed before its development. Severity of the disease at presentation and depression are the major correlates of pain burden in patients with acute HZ and postherpetic neuralgia (PHN). The frail elderly need careful assessment prior to treatment initiation and could be affected to a greater extent by treatment-related adverse events. In light of the significant burden caused by HZ and its complications in the frail elderly, the adoption of a preventive strategy appears to be promising, particularly using vaccination in appropriate age- and risk-groups. Although very few vaccine studies consider explicitly the frail elderly as their study population, there is evidence that the live, attenuated vaccine induces significant immunological responses. An adjuvanted recombinant subunit vaccine has recently been approved in Canada, in the United States, in the European Union, and in Japan, and will likely provide additional opportunities for prevention.Keywords
This publication has 53 references indexed in Scilit:
- Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort studyImmunity & Ageing, 2013
- Similar herpes zoster incidence across Europe: results from a systematic literature reviewBMC Infectious Diseases, 2013
- Balancing the Efficacy and Safety of Vaccines in the ElderlyOpen Longevity Science, 2012
- The impact of herpes zoster and post-herpetic neuralgia on quality of life: patient-reported outcomes in six European countriesJournal of Public Health, 2011
- Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: A retrospective, population-based studyBMC Infectious Diseases, 2010
- The impact of herpes zoster and post-herpetic neuralgia on quality-of-lifeBMC Medicine, 2010
- Mechanisms of immunosenescenceImmunity & Ageing, 2009
- Clinical and psychosocial correlates of post‐herpetic neuralgiaJournal of Medical Virology, 2008
- Herpes Zoster and Postherpetic NeuralgiaDrugs & Aging, 2008
- Analgesic Therapy in Postherpetic Neuralgia: A Quantitative Systematic ReviewPLOS Medicine, 2005